Skip to main content
Clinical Trials/NL-OMON50012
NL-OMON50012CompletedNot Applicable

The effect of galacto-oligosaccharides on gut complaints without medical diagnosis (e.g. bloating, constipation, diarrhea) in adult women - Darmboost

Campina0 sites80 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - 25 - 45 years of age
  • - Component (summed) score for gut complaints * 6 (based on bloating,
  • flatulence, stomach ache, constipation, diarrhea)

Exclusion Criteria

  • - Any medical diagnosed disease underlying gut-related complaints, including
  • Irritable Bowel Syndrome, celiac disease, Crohn*s disease, colitis,
  • haemorrhoids, cancer, and/or any other disease considered relevant as
  • determined during screening.
  • - Use of antibiotics, opiates, anti-inflammatory drugs (NSAIDs) and/or
  • metformin, and/or other medication that are known to affect the composition of
  • the gut microbiota during the 14 days before inclusion.
  • - Pregnant or lactating.
  • - Self-reported lactose intolerance
  • - Self-reported cow*s milk protein allergy.

Investigators

Sponsor
Campina

Similar Trials